Status:
UNKNOWN
Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies
Lead Sponsor:
Henry Ford Health System
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Carpal Tunnel Syndrome (CTS) is the most common nerve entrapment syndrome worldwide. There are currently no studies examining the effectiveness of corticosteroid injections in patients with normal (ne...
Eligibility Criteria
Inclusion
- Patients who speak English
- Patients who are 18 years or older
- Patients who are clinically diagnosed with CTS
- Patients who have a negative or mild EMG study
- Patients who receive a corticosteroid injection after obtaining a negative or mild EMG study
Exclusion
- Patients who do not speak English
- Patients who are younger than 18 years of age
- Patients who have experienced previous trauma to the wrist
- Patients who have had previous treatment for CTS including but not limited to corticosteroid injection or surgery
- Patients with a moderate or severe EMG study
Key Trial Info
Start Date :
December 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 22 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04737239
Start Date
December 23 2020
End Date
December 22 2024
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health System
Detroit, Michigan, United States, 48202